Dicerna Pharmaceuticals reported $2.98B in Market Capitalization this December of 2021, considering the latest stock price and the number of outstanding shares.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Acceleron Pharma XLRN:US $ 10.52B 2.9B
Agenus AGEN:US $ 1.22B 0B
Alnylam Pharmaceuticals ALNY:US $ 22.44B 2.51B
Amgen AMGN:US $ 120.75B 19.29B
Arrowhead Research ARWR:US $ 6.51B 2.11B
Biogen BIIB:US $ 42.18B 9.96B
Bluebird Bio BLUE:US $ 1.29B 0.87B
Dicerna Pharmaceuticals DRNA:US $ 1.57B 1.3B
Exelixis EXEL:US $ 6.66B 0.95B
Gilead Sciences GILD:US $ 87.58B 1.22B
GlaxoSmithKline GSK:LN 70.63B 794.04M
Immunogen IMGN:US $ 1.18B 0.14B
Intercept Pharmaceuticals ICPT:US $ 0.49B 0.17B
Intrexon XON:US $ 1.03B 0.31B
IONIS PHARMACEUT IONS:US $ 4.73B 0.89B
Karyopharm Therapeutics KPTI:US $ 0.44B 0.34B
Lexicon Pharmaceuticals LXRX:US $ 0.69B 0.03B
Macrogenics MGNX:US $ 1.28B 0.34B
Merk MRK:US $ 190.13B 6.79B
Mirati Therapeutics MRTX:US $ 9.13B 0.82B
Pfizer PFE:US $ 241.14B 21.94B
Regeneron Pharmaceuticals REGN:US $ 64.73B 5.23B
Regulus Therapeutics RGLS:US $ 0.06B 0B
Ultragenyx Pharmaceutical RARE:US $ 6.12B 0.32B